This trial will compare whether using CGM to diagnose GDM results in better outcomes and cost savings compared to usual care.
- Gestational Diabetes
6 Primary · 21 Secondary · Reporting Duration: Birth to discharge( upto 6 months from birth)
2 Treatment Groups
one-hour Glucose tolerance test (GCT)
1 of 2
1 of 2
816 Total Participants · 2 Treatment Groups
Primary Treatment: Group 2: CGM placement · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · Female Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does the clinical trial remain accessible to participants?
"According to clinicaltrials.gov, this medical trial is not actively enrolling new patients at the moment. The first post date was August 1st 2022 and the last update occured on June 17th of that same year. However, there are an abundance of other trials seeking participants as we speak - 1200 in total!" - Anonymous Online Contributor